cagrilintide novo + Semaglutide Novo Nordisk's next-generation weight-loss drug
Novo Nordisk's next generation weight loss drug CagriSema matches Lilly's Zepbound in major trial, but doesn't surpass it CNN Cagrilintide NOVA Labs Novo Nordisk Stock Rises on Trial Results for Cagrilintide Obesity Treatment Weight loss: New drug CagriSema leads to 14% weight loss in trial
Pay in 4 interest-free payments of $6.99 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6


:max_bytes(150000):strip_icc()/GettyImages-2197227432-6dabff12e088403c8032fbae8a53811d.jpg)